Culturing Fibroblasts from Chronic Wounds to Test Therapies
Author Information
Author(s): Harold Brem, Michael S Golinko, Olivera Stojadinovic, Arber Kodra, Robert F Diegelmann, Sasa Vukelic, Hyacinth Entero, Donald L Coppock, Marjana Tomic-Canic
Primary Institution: New York University School of Medicine
Hypothesis
Can human fibroblasts derived from chronic wounds be cultured and tested for the effects of growth factors like GM-CSF?
Conclusion
Primary cells from chronic ulcers can be established in culture and maintain their in vivo phenotype, allowing for the evaluation of wound healing stimulators.
Supporting Evidence
- Fibroblasts from different wound locations showed distinct migration capacities.
- Cells from the healing edge migrated faster than those from the wound base or non-healing edge.
- GM-CSF stimulated migration of fibroblasts from the healing edge but not from the non-healing edge.
Takeaway
Scientists can grow skin cells from people with long-lasting wounds to see how well different treatments work.
Methodology
Fibroblasts were cultured from biopsies of chronic wounds and tested for migration in response to GM-CSF.
Limitations
The study focused on a small number of patients and specific wound types.
Participant Demographics
Mean age of participants was 53.5 years, with biopsies taken from patients with chronic venous ulcers.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website